PRANDNORM

This brand name is authorized in Nigeria.

Active ingredients

The drug PRANDNORM contains one active pharmaceutical ingredient (API):

1	Sitagliptin UNII TS63EW8X6F - SITAGLIPTIN PHOSPHATE
	Sitagliptin is a member of a class of oral anti-hyperglycaemic agents called dipeptidyl peptidase 4 (DPP-4) inhibitors. The improvement in glycaemic control observed with this medicinal product may be mediated by enhancing the levels of active incretin hormones.
	Read more about Sitagliptin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9023	Tablet	PRANDNORM 50 TABLETS TAB 50 mg 3x10	141 RNW-PP-361257 PRANDNORM 50 TABLETS SITAGLIPTIN 50mg Sitagliptin Phosphate Monohydrate (6.205); Microcrystalline Cellulose (6.795); Dibasic Calcium Phosphate(5.500); (0.300); Povidone-PVPK-30 (0.40), Purified Water(4.00); Croscarmellose Sodium(0.2); Microcrystalline Cellulose-102(1.5); Colloidal Anhydrous Silica(0.1); Purified Talc(0.1); Magnesium Stearate(0.4); Colorezy white(0.5); B4-9023 Drugs Imported Products 310 Prescription Only Medicine (POM) 9/5/2023 SOLID ACCORD LTD, FEMI KILLA STREET, AGO PALACE WAY, OKOTA - LAGOS LAGOS LAGOS 8168880540 regulatory@solidaccord.com THEON PHARMACEUTICALS LIMITED, VILLAGE SAINI MAJRA, TEHSIL, NALAGARH, DISTT, SOLAN-174101 {H.P.}, INDIA, India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BH01	Sitagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
Discover more medicines within A10BH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9023, B4-9024